NextGen Healthcare (NASDAQ:NXGN) issued an update on its FY21 earnings guidance on Wednesday morning. The company provided earnings per share (EPS) guidance of $0.92-0.98 for the period, compared to the Thomson Reuters consensus estimate of $0.90. The company issued revenue guidance of $547-555 million, compared to the consensus revenue estimate of $546.79 million.NextGen Healthcare also updated its FY 2021
Pre-Market guidance to 0.92-0.98 EPS.
Several equities analysts recently weighed in on the stock. Morgan Stanley raised their price target on shares of NextGen Healthcare from $12.00 to $14.00 and gave the company an underweight rating in a research report on Monday, October 26th. SVB Leerink lifted their price objective on shares of NextGen Healthcare from $12.00 to $14.00 and gave the stock a market perform rating in a research report on Friday, October 23rd. BidaskClub raised NextGen Healthcare from a hold rating to a buy rating in a research report on Thursday, October 8th. Cantor Fitzgerald raised their price objective on shares of NextGen Healthcare from $13.00 to $15.00 and gave the stock a neutral rating in a report on Friday, October 23rd. Finally, Colliers Securities reiterated a buy rating on shares of NextGen Healthcare in a research report on Friday, December 11th. Two equities research analysts have rated the stock with a sell rating, eight have issued a hold rating and four have assigned a buy rating to the stock. The company presently has a consensus rating of Hold and an average price target of $13.13.
NASDAQ:NXGN opened at $21.26 on Thursday. The company has a current ratio of 1.64, a quick ratio of 1.64 and a debt-to-equity ratio of 0.15. NextGen Healthcare has a 12-month low of $5.10 and a 12-month high of $21.84. The stock has a 50-day moving average price of $18.36 and a 200 day moving average price of $14.60. The stock has a market capitalization of $1.42 billion, a P/E ratio of 132.85, a P/E/G ratio of 3.33 and a beta of 1.23.
In related news, Director George H. Bristol sold 4,800 shares of the company’s stock in a transaction on Thursday, December 3rd. The shares were sold at an average price of $17.52, for a total transaction of $84,096.00. Following the sale, the director now owns 67,061 shares of the company’s stock, valued at $1,174,908.72. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. 18.70% of the stock is currently owned by corporate insiders.
NextGen Healthcare Company Profile
NextGen Healthcare, Inc provides ambulatory-focused healthcare software and services solutions in the United States. The company offers NextGen Enterprise electronic health record (EHR), which stores and maintains clinical patient information; and a workflow module, prescription management, automatic document and letter generation, patient education, referral tracking, interfaces to billing and lab systems, physician alerts and reminders, and reporting and data analysis tools.
Read More: volatile stocks
Receive News & Ratings for NextGen Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NextGen Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.